Published in
Public Library of Science, PLoS ONE, 7(6), p. e22003, 2011
DOI: 10.1371/journal.pone.0022003
Links
- ORCID
- Public Library of Science
- [www.ncbi.nlm.nih.gov] | PDF
- [edoc.unibas.ch]
- [repositorio.uam.es] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [citeseerx.ist.psu.edu] | PDF
Tools
Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis
Journal article published in 2011 by
Sandra Mathis,
Bettina Khanlari,
Federico Pulido 
,
Mauro Schechter,
Eugenia Negredo,
Mark Nelson,
Pietro Vernazza,
Pedro Cahn,
Jean‐Luc-L. Meynard,
Jose Arribas,
Heiner C. Bucher
,
Mauro Schechter,
Eugenia Negredo,
Mark Nelson,
Pietro Vernazza,
Pedro Cahn,
Jean‐Luc-L. Meynard,
Jose Arribas,
Heiner C. Bucher
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
The unparalleled success of combination antiretroviral therapy (cART) is based on the combination of three drugs from two classes. There is insufficient evidence whether simplification to ritonavir boosted protease inhibitor (PI/r) monotherapy in virologically suppressed HIV-infected patients is effective and safe to reduce cART side effects and costs.